English

HTG Molecular Diagnostics, Inc

EDGAR

HTGM Quarterly report (10-Q) · filed 2023-05-11

106 filing records in this dataset, filed from 2014-12-30 to 2023-05-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.03 million USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 1032510 USD Source

Operating margin

-485.48%

2023 Q1 · %

Exact inputs and evidence

Operating Income: -5012599 USD Source
Revenue: 1032510 USD Source

Operating cash flow

-4.36 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -4363591 USD Source

Free cash flow

-4.37 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -4363591 USD Source
Capital Expenditure: 6238 USD Source

Cash and cash equivalents: 3 million USD 2023-03-31 Source
Exact value

2996409 USD
Long-term debt including current maturities: 10.7 million USD 2020-06-30 Source
Exact value

10705219 USD
Shares outstanding: 2.21 million shares 2023-03-31 Source
Exact value

2214077 shares

Reported share-count change

-74.20% · -6.37 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

8583253 shares · 2022-03-31· Source
2214077 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.21 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 1491582 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 1250879 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 6366220 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 3926915 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 1032510 USD · 2023-01-01 – 2023-03-31 Source

Net income

-20.2 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: -5888209 USD · 2022-04-01 – 2022-06-30 Source
Net income: -4516148 USD · 2022-07-01 – 2022-09-30 Source
Net income: -21594476 USD · 2022-01-01 – 2022-12-31 Source
Net income: -16901876 USD · 2022-01-01 – 2022-09-30 Source
Net income: -5054772 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

-16.8 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -11789104 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -5939563 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -16384595 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -11789104 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -18407791 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -16384595 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -4363591 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

20.9 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Capital expenditure: 15078 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 8415 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 23043 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 15078 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 23044 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 23043 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 6238 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-16.9 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -11789104 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -5939563 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -16384595 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -11789104 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -18407791 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -16384595 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -4363591 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 15078 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 8415 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 23043 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 15078 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 23044 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 23043 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 6238 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-05-11.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2022-12-31
Operating income: 9 of 11 periods available· newest 2022-12-31
Net income: 9 of 11 periods available· newest 2022-12-31
Operating cash flow: 9 of 11 periods available· newest 2022-12-31
Capital expenditure: 9 of 11 periods available· newest 2022-12-31
Total assets: 9 of 11 periods available· newest 2022-12-31
Total liabilities: 9 of 11 periods available· newest 2022-12-31
Current assets: 9 of 11 periods available· newest 2022-12-31
Current liabilities: 9 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2019-12-31
Shares outstanding: 9 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-28.5%

Prior period

USD 8.91 million

2021-01-01 – 2021-12-31
Current period

USD 6.37 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

6366220 − 8906828 = -2540608 USD

8906828 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
6366220 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Year-over-year change in Revenue: -2540608 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6366220 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#1410603 Filing: 000095017023010975 Input fundies:Revenue: 8906828 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#1412617 Filing: 000095017023010975
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.45 million

Prior period

−USD 17.15 million

2021-01-01 – 2021-12-31
Current period

−USD 21.59 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-21594476 − -17145170 = -4449306 USD

-17145170 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-21594476 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Year-over-year change in Net income: -4449306 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21594476 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#3101184 Filing: 000095017023010975 Input fundies:NetIncome: -17145170 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#3103451 Filing: 000095017023010975
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.9 million

Prior period

−USD 16.51 million

2021-01-01 – 2021-12-31
Current period

−USD 18.41 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-18407791 − -16508554 = -1899237 USD

-16508554 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-18407791 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Year-over-year change in Operating cash flow: -1899237 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -18407791 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2074543 Filing: 000095017023010975 Input fundies:OperatingCashFlow: -16508554 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2076859 Filing: 000095017023010975
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-96.4%

Prior period

USD 644,381

2021-01-01 – 2021-12-31
Current period

USD 23,044

2022-01-01 – 2022-12-31

Exact inputs and evidence

23044 − 644381 = -621337 USD

644381 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
23044 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Year-over-year change in Capital expenditure: -621337 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 23044 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2082571 Filing: 000095017023010975 Input fundies:CapitalExpenditure: 644381 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2084745 Filing: 000095017023010975
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 6.37 million 100% of revenue
Cost of revenue USD 4.57 million 72% of revenue
Operating expenses USD 22.62 million 355% of revenue
Operating income −USD 20.83 million −327% of revenue
Tax, interest and other Derived USD 764,880 12% of revenue
Net income −USD 21.59 million −339% of revenue

Cash

Operating cash flow −USD 18.41 million −289% of revenue
Capital expenditure USD 23,044 0.4% of revenue
Free cash flow Derived −USD 18.43 million −290% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Operating loss: operating costs were 486% of revenue.
2015 Operating loss: operating costs were 567% of revenue.
2016 Operating loss: operating costs were 574% of revenue.
2017 Operating loss: operating costs were 220% of revenue.
2018 Operating loss: operating costs were 175% of revenue.
2019 Operating loss: operating costs were 199% of revenue.
2020 Operating loss: operating costs were 329% of revenue.
2021 Operating loss: operating costs were 300% of revenue.
2022 Operating loss: operating costs were 427% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	3328957	16177816 Derived	-12848859	1109549 Derived	-13958408	-13854293 Derived	Source 2014-01-01 – 2014-12-31: 3328957 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -12848859 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -13958408 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -12996616 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 857677 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	4041575	22931639 Derived	-18890064	2507727 Derived	-21397791	-20581397 Derived	Source 2015-01-01 – 2015-12-31: 4041575 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -18890064 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -21397791 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -19243273 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1338124 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	5132730	29463972 Derived	-24331242	1708308 Derived	-26039550	-24180723 Derived	Source 2016-01-01 – 2016-12-31: 5132730 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -24331242 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -26039550 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -22234208 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1946515 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	14759567	32482175 Derived	-17722608	1237409 Derived	-18960017	-17592839 Derived	Source 2017-01-01 – 2017-12-31: 14759567 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -17722608 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -18960017 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -16572308 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1020531 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	21503894	37663125 Derived	-16159231	294687 Derived	-16453918	-14123432 Derived	Source 2018-01-01 – 2018-12-31: 21503894 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -16159231 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -16453918 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -13173918 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 949514 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	19203888	38163993 Derived	-18960105	337559 Derived	-19297664	-17799112 Derived	Source 2019-01-01 – 2019-12-31: 19203888 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -18960105 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -19297664 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -16695936 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1103176 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	8548864	28134503 Derived	-19585639	1284579 Derived	-20870218	-16745929 Derived	Source 2020-01-01 – 2020-12-31: 8548864 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -19585639 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -20870218 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -16292377 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 453552 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	8906828	26730654 Derived	-17823826	-678656 Derived	-17145170	-17152935 Derived	Source 2021-01-01 – 2021-12-31: 8906828 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -17823826 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -17145170 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -16508554 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 644381 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	6366220	27195816 Derived	-20829596	764880 Derived	-21594476	-18430835 Derived	Source 2022-01-01 – 2022-12-31: 6366220 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -20829596 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -21594476 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -18407791 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 23044 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.4M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	3328957	Revenue: 3328957 Open source
20152015-12-31	Revenue	4041575	Revenue: 4041575 Open source
20162016-12-31	Revenue	5132730	Revenue: 5132730 Open source
20172017-12-31	Revenue	14759567	Revenue: 14759567 Open source
20182018-12-31	Revenue	21503894	Revenue: 21503894 Open source
20192019-12-31	Revenue	19203888	Revenue: 19203888 Open source
20202020-12-31	Revenue	8548864	Revenue: 8548864 Open source
20212021-12-31	Revenue	8906828	Revenue: 8906828 Open source
20222022-12-31	Revenue	6366220	Revenue: 6366220 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-28.5% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 3328957 Open source
20152015-12-31	Year over year	21.4%	Revenue: 4041575 Open source Revenue: 3328957 Open source
20162016-12-31	Year over year	27%	Revenue: 5132730 Open source Revenue: 4041575 Open source
20172017-12-31	Year over year	187.6%	Revenue: 14759567 Open source Revenue: 5132730 Open source
20182018-12-31	Year over year	45.7%	Revenue: 21503894 Open source Revenue: 14759567 Open source
20192019-12-31	Year over year	-10.7%	Revenue: 19203888 Open source Revenue: 21503894 Open source
20202020-12-31	Year over year	-55.5%	Revenue: 8548864 Open source Revenue: 19203888 Open source
20212021-12-31	Year over year	4.2%	Revenue: 8906828 Open source Revenue: 8548864 Open source
20222022-12-31	Year over year	-28.5%	Revenue: 6366220 Open source Revenue: 8906828 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -327.2% 2022

Net margin -339.2% 2022

Free cash flow margin -289.5% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	-386%	Operating Income: -12848859 Open source Revenue: 3328957 Open source
20152015-12-31	Operating margin	-467.4%	Operating Income: -18890064 Open source Revenue: 4041575 Open source
20162016-12-31	Operating margin	-474%	Operating Income: -24331242 Open source Revenue: 5132730 Open source
20172017-12-31	Operating margin	-120.1%	Operating Income: -17722608 Open source Revenue: 14759567 Open source
20182018-12-31	Operating margin	-75.1%	Operating Income: -16159231 Open source Revenue: 21503894 Open source
20192019-12-31	Operating margin	-98.7%	Operating Income: -18960105 Open source Revenue: 19203888 Open source
20202020-12-31	Operating margin	-229.1%	Operating Income: -19585639 Open source Revenue: 8548864 Open source
20212021-12-31	Operating margin	-200.1%	Operating Income: -17823826 Open source Revenue: 8906828 Open source
20222022-12-31	Operating margin	-327.2%	Operating Income: -20829596 Open source Revenue: 6366220 Open source
20142014-12-31	Net margin	-419.3%	Net Income: -13958408 Open source Revenue: 3328957 Open source
20152015-12-31	Net margin	-529.4%	Net Income: -21397791 Open source Revenue: 4041575 Open source
20162016-12-31	Net margin	-507.3%	Net Income: -26039550 Open source Revenue: 5132730 Open source
20172017-12-31	Net margin	-128.5%	Net Income: -18960017 Open source Revenue: 14759567 Open source
20182018-12-31	Net margin	-76.5%	Net Income: -16453918 Open source Revenue: 21503894 Open source
20192019-12-31	Net margin	-100.5%	Net Income: -19297664 Open source Revenue: 19203888 Open source
20202020-12-31	Net margin	-244.1%	Net Income: -20870218 Open source Revenue: 8548864 Open source
20212021-12-31	Net margin	-192.5%	Net Income: -17145170 Open source Revenue: 8906828 Open source
20222022-12-31	Net margin	-339.2%	Net Income: -21594476 Open source Revenue: 6366220 Open source
20142014-12-31	Free cash flow margin	-416.2%	Revenue: 3328957 Open source Operating Cash Flow: -12996616 Open source Capital Expenditure: 857677 Open source
20152015-12-31	Free cash flow margin	-509.2%	Revenue: 4041575 Open source Operating Cash Flow: -19243273 Open source Capital Expenditure: 1338124 Open source
20162016-12-31	Free cash flow margin	-471.1%	Revenue: 5132730 Open source Operating Cash Flow: -22234208 Open source Capital Expenditure: 1946515 Open source
20172017-12-31	Free cash flow margin	-119.2%	Revenue: 14759567 Open source Operating Cash Flow: -16572308 Open source Capital Expenditure: 1020531 Open source
20182018-12-31	Free cash flow margin	-65.7%	Revenue: 21503894 Open source Operating Cash Flow: -13173918 Open source Capital Expenditure: 949514 Open source
20192019-12-31	Free cash flow margin	-92.7%	Revenue: 19203888 Open source Operating Cash Flow: -16695936 Open source Capital Expenditure: 1103176 Open source
20202020-12-31	Free cash flow margin	-195.9%	Revenue: 8548864 Open source Operating Cash Flow: -16292377 Open source Capital Expenditure: 453552 Open source
20212021-12-31	Free cash flow margin	-192.6%	Revenue: 8906828 Open source Operating Cash Flow: -16508554 Open source Capital Expenditure: 644381 Open source
20222022-12-31	Free cash flow margin	-289.5%	Revenue: 6366220 Open source Operating Cash Flow: -18407791 Open source Capital Expenditure: 23044 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -18.4M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	-12996616	Operating Cash Flow: -12996616 Open source
20152015-12-31	Operating cash flow	-19243273	Operating Cash Flow: -19243273 Open source
20162016-12-31	Operating cash flow	-22234208	Operating Cash Flow: -22234208 Open source
20172017-12-31	Operating cash flow	-16572308	Operating Cash Flow: -16572308 Open source
20182018-12-31	Operating cash flow	-13173918	Operating Cash Flow: -13173918 Open source
20192019-12-31	Operating cash flow	-16695936	Operating Cash Flow: -16695936 Open source
20202020-12-31	Operating cash flow	-16292377	Operating Cash Flow: -16292377 Open source
20212021-12-31	Operating cash flow	-16508554	Operating Cash Flow: -16508554 Open source
20222022-12-31	Operating cash flow	-18407791	Operating Cash Flow: -18407791 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -18.4M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	-13854293	Operating Cash Flow: -12996616 Open source Capital Expenditure: 857677 Open source
20152015-12-31	Free cash flow	-20581397	Operating Cash Flow: -19243273 Open source Capital Expenditure: 1338124 Open source
20162016-12-31	Free cash flow	-24180723	Operating Cash Flow: -22234208 Open source Capital Expenditure: 1946515 Open source
20172017-12-31	Free cash flow	-17592839	Operating Cash Flow: -16572308 Open source Capital Expenditure: 1020531 Open source
20182018-12-31	Free cash flow	-14123432	Operating Cash Flow: -13173918 Open source Capital Expenditure: 949514 Open source
20192019-12-31	Free cash flow	-17799112	Operating Cash Flow: -16695936 Open source Capital Expenditure: 1103176 Open source
20202020-12-31	Free cash flow	-16745929	Operating Cash Flow: -16292377 Open source Capital Expenditure: 453552 Open source
20212021-12-31	Free cash flow	-17152935	Operating Cash Flow: -16508554 Open source Capital Expenditure: 644381 Open source
20222022-12-31	Free cash flow	-18430835	Operating Cash Flow: -18407791 Open source Capital Expenditure: 23044 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

69.7% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	257.5%	Total Liabilities: 22475579 Open source Total Assets: 8728246 Open source
20152015-12-31	Liabilities / assets	57.1%	Total Liabilities: 22500970 Open source Total Assets: 39394368 Open source
20162016-12-31	Liabilities / assets	130.3%	Total Liabilities: 24047071 Open source Total Assets: 18454209 Open source
20172017-12-31	Liabilities / assets	114.4%	Total Liabilities: 24315837 Open source Total Assets: 21256300 Open source
20182018-12-31	Liabilities / assets	51.8%	Total Liabilities: 22679218 Open source Total Assets: 43771280 Open source
20192019-12-31	Liabilities / assets	46.9%	Total Liabilities: 21149635 Open source Total Assets: 45119269 Open source
20202020-12-31	Liabilities / assets	58.8%	Total Liabilities: 20713248 Open source Total Assets: 35197908 Open source
20212021-12-31	Liabilities / assets	65.9%	Total Liabilities: 20060863 Open source Total Assets: 30460687 Open source
20222022-12-31	Liabilities / assets	69.7%	Total Liabilities: 12385958 Open source Total Assets: 17777655 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.89× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	1.88×	Current Assets: 6212366 Open source Current Liabilities: 3303142 Open source
20152015-12-31	Current assets / current liabilities	5.52×	Current Assets: 34858254 Open source Current Liabilities: 6319610 Open source
20162016-12-31	Current assets / current liabilities	1.51×	Current Assets: 15134382 Open source Current Liabilities: 10020991 Open source
20172017-12-31	Current assets / current liabilities	1.35×	Current Assets: 17948457 Open source Current Liabilities: 13341967 Open source
20182018-12-31	Current assets / current liabilities	5.41×	Current Assets: 37951938 Open source Current Liabilities: 7017374 Open source
20192019-12-31	Current assets / current liabilities	4.65×	Current Assets: 41367582 Open source Current Liabilities: 8898859 Open source
20202020-12-31	Current assets / current liabilities	4.54×	Current Assets: 32871053 Open source Current Liabilities: 7236374 Open source
20212021-12-31	Current assets / current liabilities	2.73×	Current Assets: 27186964 Open source Current Liabilities: 9943510 Open source
20222022-12-31	Current assets / current liabilities	1.89×	Current Assets: 15651451 Open source Current Liabilities: 8270757 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 13.96 million Exact value Exact value: -13958408 USD 2014-01-01 – 2014-12-31: -13958408 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2014-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -13958408 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13958408 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459016015252/htgm-20151231.xml#227249 Filing: 000156459016015252 The citation records this snapshot. The page link may show a newer release later.	−USD 13 million Exact value Exact value: -12996616 USD 2014-01-01 – 2014-12-31: -12996616 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2014-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -12996616 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12996616 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459016015252/htgm-20151231.xml#279392 Filing: 000156459016015252 The citation records this snapshot. The page link may show a newer release later.	USD 857,677 Exact value Exact value: 857677 USD 2014-01-01 – 2014-12-31: 857677 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2014-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 857677 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 857677 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459016015252/htgm-20151231.xml#279852 Filing: 000156459016015252 The citation records this snapshot. The page link may show a newer release later.	−USD 13.85 million Calculation and evidence -12996616 − 857677 USD Exact free cash flow: -13854293 USD 2014-01-01 – 2014-12-31: -12996616 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 857677 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2014-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -13854293 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12996616 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459016015252/htgm-20151231.xml#279392 Filing: 000156459016015252 Input fundies:CapitalExpenditure: 857677 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459016015252/htgm-20151231.xml#279852 Filing: 000156459016015252 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 21.4 million Exact value Exact value: -21397791 USD 2015-01-01 – 2015-12-31: -21397791 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2015-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -21397791 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21397791 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459017005153/htgm-20161231.xml#199159 Filing: 000156459017005153 The citation records this snapshot. The page link may show a newer release later.	−USD 19.24 million Exact value Exact value: -19243273 USD 2015-01-01 – 2015-12-31: -19243273 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2015-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -19243273 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19243273 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459017005153/htgm-20161231.xml#240375 Filing: 000156459017005153 The citation records this snapshot. The page link may show a newer release later.	USD 1.34 million Exact value Exact value: 1338124 USD 2015-01-01 – 2015-12-31: 1338124 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2015-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 1338124 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1338124 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459017005153/htgm-20161231.xml#240835 Filing: 000156459017005153 The citation records this snapshot. The page link may show a newer release later.	−USD 20.58 million Calculation and evidence -19243273 − 1338124 USD Exact free cash flow: -20581397 USD 2015-01-01 – 2015-12-31: -19243273 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1338124 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2015-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -20581397 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19243273 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459017005153/htgm-20161231.xml#240375 Filing: 000156459017005153 Input fundies:CapitalExpenditure: 1338124 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459017005153/htgm-20161231.xml#240835 Filing: 000156459017005153 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 26.04 million Exact value Exact value: -26039550 USD 2016-01-01 – 2016-12-31: -26039550 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2016-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -26039550 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26039550 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459018006602/htgm-20171231.xml#184455 Filing: 000156459018006602 The citation records this snapshot. The page link may show a newer release later.	−USD 22.23 million Exact value Exact value: -22234208 USD 2016-01-01 – 2016-12-31: -22234208 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2016-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -22234208 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22234208 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459018006602/htgm-20171231.xml#209128 Filing: 000156459018006602 The citation records this snapshot. The page link may show a newer release later.	USD 1.95 million Exact value Exact value: 1946515 USD 2016-01-01 – 2016-12-31: 1946515 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2016-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 1946515 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1946515 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459018006602/htgm-20171231.xml#209588 Filing: 000156459018006602 The citation records this snapshot. The page link may show a newer release later.	−USD 24.18 million Calculation and evidence -22234208 − 1946515 USD Exact free cash flow: -24180723 USD 2016-01-01 – 2016-12-31: -22234208 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1946515 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2016-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -24180723 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22234208 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459018006602/htgm-20171231.xml#209128 Filing: 000156459018006602 Input fundies:CapitalExpenditure: 1946515 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459018006602/htgm-20171231.xml#209588 Filing: 000156459018006602 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 18.96 million Exact value Exact value: -18960017 USD 2017-01-01 – 2017-12-31: -18960017 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2017-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -18960017 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18960017 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/htgm-20181231.xml#211102 Filing: 000156459019006806 The citation records this snapshot. The page link may show a newer release later.	−USD 16.57 million Exact value Exact value: -16572308 USD 2017-01-01 – 2017-12-31: -16572308 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2017-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -16572308 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16572308 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/htgm-20181231.xml#239797 Filing: 000156459019006806 The citation records this snapshot. The page link may show a newer release later.	USD 1.02 million Exact value Exact value: 1020531 USD 2017-01-01 – 2017-12-31: 1020531 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2017-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 1020531 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1020531 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/htgm-20181231.xml#240216 Filing: 000156459019006806 The citation records this snapshot. The page link may show a newer release later.	−USD 17.59 million Calculation and evidence -16572308 − 1020531 USD Exact free cash flow: -17592839 USD 2017-01-01 – 2017-12-31: -16572308 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1020531 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2017-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -17592839 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16572308 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/htgm-20181231.xml#239797 Filing: 000156459019006806 Input fundies:CapitalExpenditure: 1020531 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/htgm-20181231.xml#240216 Filing: 000156459019006806 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 16.45 million Exact value Exact value: -16453918 USD 2018-01-01 – 2018-12-31: -16453918 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2018-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -16453918 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16453918 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/htgm-20191231.xml#254774 Filing: 000156459020012877 The citation records this snapshot. The page link may show a newer release later.	−USD 13.17 million Exact value Exact value: -13173918 USD 2018-01-01 – 2018-12-31: -13173918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2018-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -13173918 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13173918 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/htgm-20191231.xml#285841 Filing: 000156459020012877 The citation records this snapshot. The page link may show a newer release later.	USD 949,514 Exact value Exact value: 949514 USD 2018-01-01 – 2018-12-31: 949514 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2018-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 949514 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 949514 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/htgm-20191231.xml#286261 Filing: 000156459020012877 The citation records this snapshot. The page link may show a newer release later.	−USD 14.12 million Calculation and evidence -13173918 − 949514 USD Exact free cash flow: -14123432 USD 2018-01-01 – 2018-12-31: -13173918 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 949514 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2018-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -14123432 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13173918 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/htgm-20191231.xml#285841 Filing: 000156459020012877 Input fundies:CapitalExpenditure: 949514 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/htgm-20191231.xml#286261 Filing: 000156459020012877 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 19.3 million Exact value Exact value: -19297664 USD 2019-01-01 – 2019-12-31: -19297664 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2019-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -19297664 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19297664 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459021015554/htgm-20201231.xml#239956 Filing: 000156459021015554 The citation records this snapshot. The page link may show a newer release later.	−USD 16.7 million Exact value Exact value: -16695936 USD 2019-01-01 – 2019-12-31: -16695936 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2019-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -16695936 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16695936 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459021015554/htgm-20201231.xml#278663 Filing: 000156459021015554 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Exact value Exact value: 1103176 USD 2019-01-01 – 2019-12-31: 1103176 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2019-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 1103176 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1103176 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459021015554/htgm-20201231.xml#279082 Filing: 000156459021015554 The citation records this snapshot. The page link may show a newer release later.	−USD 17.8 million Calculation and evidence -16695936 − 1103176 USD Exact free cash flow: -17799112 USD 2019-01-01 – 2019-12-31: -16695936 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1103176 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2019-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -17799112 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16695936 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459021015554/htgm-20201231.xml#278663 Filing: 000156459021015554 Input fundies:CapitalExpenditure: 1103176 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459021015554/htgm-20201231.xml#279082 Filing: 000156459021015554 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 20.87 million Exact value Exact value: -20870218 USD 2020-01-01 – 2020-12-31: -20870218 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2020-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -20870218 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20870218 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459022012240/htgm-10k_20211231.htm#3198056 Filing: 000156459022012240 The citation records this snapshot. The page link may show a newer release later.	−USD 16.29 million Exact value Exact value: -16292377 USD 2020-01-01 – 2020-12-31: -16292377 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2020-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -16292377 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16292377 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459022012240/htgm-10k_20211231.htm#2195761 Filing: 000156459022012240 The citation records this snapshot. The page link may show a newer release later.	USD 453,552 Exact value Exact value: 453552 USD 2020-01-01 – 2020-12-31: 453552 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2020-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 453552 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 453552 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459022012240/htgm-10k_20211231.htm#2203364 Filing: 000156459022012240 The citation records this snapshot. The page link may show a newer release later.	−USD 16.75 million Calculation and evidence -16292377 − 453552 USD Exact free cash flow: -16745929 USD 2020-01-01 – 2020-12-31: -16292377 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 453552 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2020-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -16745929 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16292377 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459022012240/htgm-10k_20211231.htm#2195761 Filing: 000156459022012240 Input fundies:CapitalExpenditure: 453552 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000156459022012240/htgm-10k_20211231.htm#2203364 Filing: 000156459022012240 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 17.15 million Exact value Exact value: -17145170 USD 2021-01-01 – 2021-12-31: -17145170 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2021-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -17145170 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17145170 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#3103451 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	−USD 16.51 million Exact value Exact value: -16508554 USD 2021-01-01 – 2021-12-31: -16508554 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2021-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -16508554 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16508554 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2076859 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	USD 644,381 Exact value Exact value: 644381 USD 2021-01-01 – 2021-12-31: 644381 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2021-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 644381 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 644381 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2084745 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	−USD 17.15 million Calculation and evidence -16508554 − 644381 USD Exact free cash flow: -17152935 USD 2021-01-01 – 2021-12-31: -16508554 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 644381 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2021-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -17152935 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16508554 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2076859 Filing: 000095017023010975 Input fundies:CapitalExpenditure: 644381 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2084745 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 21.59 million Exact value Exact value: -21594476 USD 2022-01-01 – 2022-12-31: -21594476 USD Inspect Net Income Open source Share or cite Citation for Net Income · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Net Income: -21594476 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21594476 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#3101184 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	−USD 18.41 million Exact value Exact value: -18407791 USD 2022-01-01 – 2022-12-31: -18407791 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Operating Cash Flow: -18407791 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18407791 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2074543 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	USD 23,044 Exact value Exact value: 23044 USD 2022-01-01 – 2022-12-31: 23044 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Capital Expenditure: 23044 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23044 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2082571 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.	−USD 18.43 million Calculation and evidence -18407791 − 23044 USD Exact free cash flow: -18430835 USD 2022-01-01 – 2022-12-31: -18407791 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 23044 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HTG Molecular Diagnostics, Inc · 2022-12-31 HTG Molecular Diagnostics, Inc (edgar:1169987) Free cash flow: -18430835 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:15:44Z Snapshot: fe52393193fe88cdbe67854c075a6b10e64115c50a7b1002ff52be9fabceeea2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1169987?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18407791 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2074543 Filing: 000095017023010975 Input fundies:CapitalExpenditure: 23044 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1169987/000095017023010975/htgm-20221231.htm#2082571 Filing: 000095017023010975 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

106 filings · 2,649 latest values · 2,649 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001169987, 1169987, HTGM, edgar:1169987

Also known as HIGH THROUGHPUT GENOMICS INC, HTG MOLECULAR DIAGNOSTICS INC, HTG MOLECULAR DIAGNOSTICS, INC, HTG Molecular Diagnostics, Inc

HTG Molecular Diagnostics, Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation